Oxford Spinout goes for $75M IPO on Nasdaq to Fund Gene Therapy Programs – Labiotech.eu (blog)
Labiotech.eu (blog) |
Oxford Spinout goes for $75M IPO on Nasdaq to Fund Gene Therapy Programs
Labiotech.eu (blog) Nightstar has gone public on the American market with the aim of raising $75M for its gene-based retinal disease cures. Spun out from Oxford in 2013, Nightstar is developing and commercializing one-shot gene therapies for various eye diseases that … Nightstar Therapeutics (Nasdaq: NITE) to Ring The Nasdaq Stock Market Closing Bell in Celebration of Its IPO Syncona's Nightstar reveals details on US IPO |
